{
  "docId": "019de076-8e54-70f4-b1ec-6643014b872e",
  "docSlug": "869b7bb859e037e0c2aa4b6e5865c5ed",
  "documentTitle": "AbCellera | Investor Conference Presentation Deck | 14 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 14,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-8e54-70f4-b1ec-6643014b872e/9",
  "deckHref": "/decks/019de076-8e54-70f4-b1ec-6643014b872e",
  "deckJsonHref": "/decks/019de076-8e54-70f4-b1ec-6643014b872e.json",
  "deckAnchorHref": "/decks/019de076-8e54-70f4-b1ec-6643014b872e#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.074,
        "w": 0.35,
        "x": 0.094,
        "y": 0.656
      },
      "kind": "paragraph",
      "text": "ABCL635 is the first AbCellera-led asset derived from our GPCR and ion channel platform.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02b56081-0610-4d09-ab71-03a9aa6ee2be",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.635,
        "w": 0.472,
        "x": 0.472,
        "y": 0.102
      },
      "kind": "table",
      "text": "Molecule: ABCL635; Status: IND-enabling studies (Preclinical); Target: Undisclosed - GPCR or ion channel; MOA: Antagonist; Indication: Undisclosed; Therapeutic Area: Metabolic & endocrine conditions; Market Opportunity: >$2B; Potential Differentiation: First-in-class",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3cca9723-1517-4cf7-a952-3dda847425ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.185,
        "w": 0.35,
        "x": 0.094,
        "y": 0.244
      },
      "kind": "title",
      "text": "A potential first-in-class antibody therapy for metabolic and endocrine conditions.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c0f5512-b263-44f4-acbd-95303ae4dd9d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.221,
        "x": 0.094,
        "y": 0.044
      },
      "kind": "title",
      "text": "OUR PIPELINE – ABCL635",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b34471e0-804f-49c0-b588-2d77694cc242",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}